Sept. 27 Financial Quick Takes: Beam hops into IPO queue; plus Amryt, T3, Junshi, Newronika

By BioCentury Staff | Sep 27, 2019 | 11:32 PM GMT

Beam seeking NASDAQ IPO
Beam Therapeutics filed to raise up to $100 million in an IPO underwritten by J.P. Morgan, Jefferies, Barclays and Wedbush PacGrow. The base editing company has 12 preclinical programs across hematology, oncology, liver, ocular and CNS